Investing News NetworkYour trusted source for investing success

Videos
Companies
Press Releases
Top Stocks
Top Resource Stocks
Top Tech Stocks
Top Life Science Stocks
Private Placements
Trending
Trending Articles

Could the Silver Price Really Hit US$100 per Ounce? (Updated 2024)

How Would a New BRICS Currency Affect the US Dollar? (Updated 2024)

Top 10 Countries for Natural Gas Production (Updated 2024)

Top 10 Copper-producing Companies (Updated 2024)

7 Biggest Lithium-mining Companies

Top 7 Canadian Lithium Stocks of 2024

Hydrogen Stocks: 9 Biggest Companies

Where Does Tesla Get its Lithium? (Updated 2024)

11 Canadian Cryptocurrency ETFs (Updated 2024)

Trending Press Releases

Edison Lithium Expands Portfolio with Acquisition of Additional Sodium Brine Claim in Saskatchewan

Galan Lithium Limited (ASX: GLN) – Trading Halt

Bitcoin Well Launches Cash Vouchers For Canadian Customers

Osisko Metals Reports Preliminary Metallurgical Testwork Results From Gaspé Copper

Mineral Resource Update – Mt Boppy Gold Project

Victory Battery Metals Corp. Options Kachiwiss Uranium Project and Other Uranium Anomalies

More Press Releases
Trending Companies

Trident Royalties PLC

TDTRF

Impact Minerals Limited

IPT:AU

Ramp Metals

RAMP:CC

Purpose Bitcoin ETF

BTCC:CA
More Companies
Trending Reports

2024 Uranium Outlook (Updated for Q2)

2024 Copper Market Outlook (Australia Ed.)

2024 Lithium Market Outlook

Lithium Outlook for Australia

More Outlook Reports
Resource
Resource
Popular Lists
Investing Ideas
Outlook Reports
Investing Guides
Tech
Tech
Popular Lists
Investing Ideas
Outlook Reports
Investing Guides
Life Science
Life Science
Popular Lists
Investing Ideas
Outlook Reports
Investing Guides
Gold
Copper
Uranium
Oil and Gas
Artificial Intelligence
Biotech
loader

Mind Medicine (MindMed) Inc.

NASDAQ:MNMD
Press Releases

Mind Medicine Inc is a psychedelic medicine biotech company that discovers, develops, and deploys psychedelic inspired medicines and therapies to address addiction and mental illness. The company is assembling a compelling drug development pipeline of treatments based on psychedelic substances including Psilocybin, LSD, MDMA, DMT, and an Ibogaine derivative, 18-MC. The firm is having an approach towards developing the next generation of psychedelic inspired medicines and therapies.

×